Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 102, Issue 4, 2006, Pages

  Bruce, Alison J ^a   Subtil, Antonio ^b   Rogers III, Roy S ^a   Castro, Luis A ^a  

^a MAYO CLINIC   (United States)

^b YALE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN; VIRUS RNA;

ARTICLE; B CELL LYMPHOMA; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LARGE CELL LYMPHOMA; MIDDLE AGED; MOUTH TUMOR; MOUTH ULCER; PANCREAS TRANSPLANTATION; TONGUE DISEASE; VIROLOGY; VIRUS INFECTION;

DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MIDDLE AGED; MOUTH NEOPLASMS; ORAL ULCER; PANCREAS TRANSPLANTATION; RNA, VIRAL; SIROLIMUS; TONGUE DISEASES;

EID: 33748748115     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.01.014     Document Type: Article

References (26)

1. Harris N.L., Swerdlow S.H., Frizzera G., and Knowles D.M. Post-transplant lymphoproliferative disorders. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 264-269
2. Bruce A.J., and Rogers III R.S. Acute oral ulcers. Dermatol Clin 21 (2003) 1-15
3. Armstrong C., Napier S., and Linden G.J. Sarcoidosis with gingival involvement: a case report. J Periodontol 75 (2004) 608-612
4. Scott C.M., and Flint S.R. Oral syphilis: re-emergence of an old disease with oral manifestations. Int J Oral Maxillofac Surg 34 (2005) 58-63
5. Ito F.A., de Andrade C.R., Vargas P.A., Jorge J., and Lopes M.A. Primary tuberculosis of the oral cavity. Oral Dis 11 (2005) 50-53
6. Colombo P., Tondulli L., Masci G., Muzza A., Rimassa L., Petrella D., et al. Oral ulcer as an exclusive sign of gastric cancer: report of a rare case. BMC Cancer 5 (2005) 117
7. MacBean A.D., Fan K.F., and Darwish C. Interesting case: lessons learnt. Br J Oral Maxillofac Surg 43 (2005) 425
8. Chen N., Francois A., Moguelet P., and Peron J.M. Difficult diagnosis for a lingual ulceration: Wegener granulomatosis [in French]. Rev Stomatol Chir Maxillofac 103 (2002) 304-306
9. Oda D., Persson G.R., Haigh W.G., Sabath D.E., Penn I., and Aziz S. Oral presentation of posttransplantation lymphoproliferative disorders: an unusual manifestation. Transplantation 61 (1996) 435-440
10. Solomides C.C., Miller A.S., Christman R.A., Talwar J., and Simpkins H. Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol 33 (2002) 153-157
11. Leong I.T., Fernandes B.J., and Mock D. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 184-193
12. Rolland S.L., Seymour R.A., Wilkins B.S., Parry G., and Thomason J.M. Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with cyclosporin: a report of two cases. J Clin Periodontol 31 (2004) 581-585
13. Lundell R., Elenitoba-Johnson K.S., and Lim M.S. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol 28 (2004) 967-973
14. Nalesnik M.A., Jaffe R., Starzl T.E., Demetris A.J., Porter K., Burnham J.A., et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133 (1988) 173-192
15. Tsai D.E., Hardy C.L., Tomaszewski J.E., Kotloff R.M., Oltoff K.M., Somer B.G., et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 71 (2001) 1076-1088
16. Hanasono M.M., Parrett B.M., and Breitbart A.S. Posttransplant lymphoproliferative disorder presenting as a cutaneous forehead mass. Otolaryngol Head Neck Surg 130 (2004) 372-374
17. Wong J.Y., Tait B., Levvey B., Griffiths A., Esmore D.S., Snell G.I., et al. Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease. Transplantation 78 (2004) 205-210
18. Starzl T.E., Nalesnik M.A., Porter K.A., Ho M., Iwatsuki S., Griffith B.P., et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1 (1984) 583-587
19. Lones M.A., Mishalani S., Shintaku I.P., Weiss L.M., Nichols W.S., and Said J.W. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring. Hum Pathol 26 (1995) 525-530
20. Jankowska I., Pawlowska J., Kaliciñski P., Teisseyre M., Czubkowski P., Gliwicz D., et al. Posttransplant lymphoproliferative disease (PTLD) after liver transplantation in children: own experience [abstract]. J Pediatr Gastroenterol Nutr 39 (2004) s150-s151
21. Knowles D.M., Cesarman E., Chadburn A., Frizzera G., Chen J., Rose E.A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85 (1995) 552-565
22. Nowalk A.J., and Green M. Diagnosis, prevention, and management of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in organ transplant recipients. Curr Opin Organ Transplant 8 (2003) 276-282
23. Gulley M.L., Swinnen L.J., Plaisance Jr. K.T., Schnell C., Grogan T.M., Schneider B.G., and Southwest Oncology Group. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy. Transplantation 76 (2003) 959-964
24. Curtis R.E., Travis L.B., Rowlings P.A., Socie G., Kingma D.W., Banks P.M., et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94 (1999) 2208-2216
25. Abed N., Casper J.T., Camitta B.M., Margolis D., Trost B., Orentas R., et al. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. Bone Marrow Transplant 33 (2004) 321-327
26. Shoji N., Ohyashiki J.H., Suzuki A., Kubota N., Kimura Y., Matsubayashi J., et al. Multiple pulmonary nodules caused by B-cell post-transplant lymphoproliferative disorder after bone marrow transplantation: monitoring Epstein-Barr virus viral load. Jpn J Clin Oncol 33 (2003) 408-412